Breathe Well Live Well
|
HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation
News-Medical.net The addition of a house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet to maintenance medications improved time to first moderate or severe asthma exacerbation during a period of inhaled corticosteroid (ICS) reduction among adults with … House dust mite immunotherapy in adults with allergic asthma |
View full post on asthma – Google News
MedPage Today |
Outcomes of immunotherapy tablet for house dust mite allergy-related asthma
Science Daily Bronchial asthma is a serious global health problem with increasing prevalence in many countries. House dust mite sensitization is present in up to 50 percent of patients with asthma, and exposure to HDM allergen has been related to asthma severity. Dust Mite SLIT Promising Add-On to Asthma Maintenance Meds Journal of the American Medical Association Publishes Phase III Data from Allergic Asthma Trial with ALK's House … |
View full post on asthma – Google News
Medical Xpress |
Outcomes of immunotherapy tablet for house dust mite allergy-related asthma
Medical Xpress Bronchial asthma is a serious global health problem with increasing prevalence in many countries. House dust mite sensitization is present in up to 50 percent of patients with asthma, and exposure to HDM allergen has been related to asthma severity. Dust Mite SLIT Promising Add-On to Asthma Maintenance Meds Journal of the American Medical Association Publishes Phase III Data from Allergic Asthma Trial with ALK's House … |
View full post on asthma – Google News
| Related Articles |
A major step forward for sublingual immunotherapy: the quality of 5-grass pollen tablet is recognized also in Italy.
J Asthma Allergy. 2015;8:25-7
Authors: Ciprandi G
PMID: 25834457 [PubMed]
View full post on pubmed: asthma
Condition: Respiratory Disorders
Interventions: Drug: Reference Montelukast; Drug: Test 1 Montelukast; Drug: Test 2 Montelukast
Sponsor: GlaxoSmithKline
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Sublingual immunotherapy tablet safe in asthma patients
Medical Xpress (HealthDay)—For individuals with asthma and allergic rhinitis with/without conjunctivitis (AR/C), treatment with a Timothy grass sublingual immunotherapy tablet (SLIT-tablet) seems safe, according to research published online Dec. 14 in Allergy. |
View full post on asthma – Google News
Condition: Allergic Rhinitis
Interventions: Drug: Grazax; Drug: Grazax Placebo
Sponsors: Imperial College London; King’s College London; ALK-Abelló A/S; Wellcome Trust
Not yet recruiting – verified December 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
 Daily Mail |
A tablet made from a protein found in house dust mites could revolutionise the …
Daily Mail The pill, which melts under the tongue, is designed to re-tune the immune system so that it does not over-react when it comes into contact with mite droppings, which are a leading trigger for asthma attacks. Early trial results show patients who take … |
View full post on asthma – Google News